Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bayer AG | 39 | 5 | 1 | 0 | €53.20 | €73.00 | 37.218% |
| Pfizer Inc. | 29 | 2 | 1 | 0 | €29.34 | €36.28 | 23.663% |
| Fresenius SE & Co. KGaA | 32 | 5 | 2 | 0 | €36.71 | €50.00 | 36.203% |
| Evotec AG | 29 | 3 | 0 | 0 | €28.78 | €37.00 | 28.562% |
| Johnson & Johnson | 19 | 1 | 1 | 0 | €133.68 | €144.50 | 8.094% |
| AbbVie Inc. | 16 | 1 | 1 | 0 | €91.13 | €100.00 | 9.733% |
| Canopy Growth Corp | 16 | 3 | 3 | 0 | €27.02 | €50.00 | 85.048% |
| Bristol-Myers Squibb | 13 | 0 | 0 | 0 | €51.55 | €60.32 | 17.003% |
| Fresenius Medical Care AG & Co KGaA ST | 15 | 2 | 2 | 1 | €58.82 | €80.00 | 36.008% |
| Novo Nordisk A/S | 12 | 1 | 0 | 0 | €59.00 | €66.00 | 11.864% |
| MorphoSys AG | 13 | 2 | 2 | 0 | €81.74 | €124.00 | 51.701% |
| Paion AG | 12 | 2 | 2 | 0 | €2.30 | €4.00 | 73.913% |
| Incyte Corp. | 12 | 2 | 1 | 1 | €68.17 | €110.00 | 61.361% |
| Abbott Laboratories | 11 | 1 | 1 | 0 | €99.18 | €109.95 | 10.859% |
| Palatin Technologies | 12 | 2 | 1 | 0 | €0.62 | €1.05 | 70.344% |
| Vertex Pharmaceuticals Inc. | 10 | 1 | 0 | 0 | €183.54 | €260.00 | 41.658% |
| AstraZeneca plc | 11 | 2 | 1 | 0 | €81.80 | €100.00 | 22.249% |
| Carl Zeiss Meditec AG | 9 | 0 | 0 | 0 | €121.40 | €115.00 | -5.272% |
| Aphria Inc. | 10 | 2 | 1 | 0 | €13.77 | €15.40 | 11.837% |
| UnitedHealth Group Inc. | 9 | 1 | 0 | 0 | €296.95 | €300.00 | 1.027% |
| Bausch Health Companies Inc. | 9 | 1 | 1 | 0 | €28.05 | €29.30 | 4.475% |
| Illumina Inc. | 8 | 0 | 0 | 0 | €337.05 | €343.44 | 1.896% |
| Alexion Pharmaceutical Inc. | 9 | 1 | 0 | 0 | €126.00 | €131.00 | 3.968% |
| Align Technology | 9 | 1 | 0 | 1 | €448.10 | €504.00 | 12.475% |
| Merck KGaA | 10 | 2 | 1 | 0 | €130.00 | €137.00 | 5.385% |
